The Zhitong Finance App learned that LLY.US (LLY.US) has agreed to acquire the privately held Calytrix Bio Inc., with a transaction value of up to 1.5 billion US dollars. This is Lilly's latest move to continue to acquire and lay out the cancer and autoimmune disease racetrack.

Zhitongcaijing · 2d ago
The Zhitong Finance App learned that LLY.US (LLY.US) has agreed to acquire the privately held Calytrix Bio Inc., with a transaction value of up to 1.5 billion US dollars. This is Lilly's latest move to continue to acquire and lay out the cancer and autoimmune disease racetrack.